AI assistant
ORTHOCELL LIMITED — Capital/Financing Update 2014
Aug 6, 2014
65477_rns_2014-08-06_ba9aa731-90dd-4bd0-85b3-74df715342cd.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [596 x 126] intentionally omitted <==
----- Start of picture text -----
Notice
Notice reference number: 0863.14.08 Notice date: 7/08/2014
----- End of picture text -----
What’s this about? Effective date: 7/08/2014 ASX Trade ASX 24 Trading Clearing Settlement Operations Technology Market Data Rules Compliance Risk Other
What’s this about?
Title
Orthocell Limited – Admission and Commencement of Official Quotation
Description
Orthocell Limited (Company) was admitted to the Official List of ASX Limited (ASX) on Thursday, 7 August 2014.
Official quotation of the Company’s securities will commence at 1:30 pm Australian Eastern Standard Time (AEST) on Tuesday, 12 August 2014. The Company has raised $8 million pursuant to the offer under the prospectus dated 28 May 2014 issued by the Company (Prospectus) by the issue of 20,000,000 ordinary shares at an issue price of $0.40 per share.
Quoted Securities: 55,271,834 fully paid ordinary shares ASX Code: OCC Time: 1:30 pm AEST Date: Tuesday, 12 August 2014 ASX Trade Abbreviation: ORTHOCELL ISIN: AU000000OCC6 Home Branch: Perth Industry Classification: 3520 Pharmaceuticals, Biotechnology & Life Sciences Registered Office: Building 191 Murdoch University South Street Murdoch WA 6150 Ph: (08) 9360 2888 Fx: (08) 9360 2899 Company Secretary: Simon Robertson Share Registry: Automic Registry Services Suite 1A, Level 1 7 Ventnor Avenue West Perth, WA 6005 Ph: (08) 9324 2099 Fx: (08) 9321 2337 Balance Date: 30 June
Page 1 of 2
(continued)
ASX Notice Notice
CHESS: Participating. The Company will also operate an issuer sponsored sub-register. Place of Incorporation: Victoria
Dividend Policy: See section 1.4 of the Prospectus Activities: Regenerative medicine sector for chronic degenerative diseases and injury ASX Restricted Securities: 27,185,515 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow for a period of 24 months from the commencement of official quotation 42,651 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow for a period of 12 months from 23 May 2014 4,250,000 options exercisable at $0.50 on or before 3 August 2017, classified by ASX as restricted securities and to be held in escrow for a period of 24 months from the commencement of official quotation 1,662,500 options exercisable at $0.50 on or before 3 August 2017, classified by ASX as restricted securities and to be held in escrow for a period of 12 months from 3 August 2014
What do I need to do and by when?
For further details, please refer to the Company’s prospectus dated 28 May 2014.
Need more information?
For further details, please refer to the Company’s prospectus dated 28 May 2014.
Issued by Jeremy Newman
4B
Contact Details (08) 9224 0029
Disclaimer
Page 2 of 2